18 May 2013
Keywords: vigabatrin, nda, filed, usa, marion, merrell, dow
Article | 18 July 1994
Marion Merrell Dow has filed a New Drug Application with the US Food and Drug Administration for Sabril (vigabatrin), which ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.